AnaptysBio Inc sell JPMorgan Chase & Co.
Start price
13.04.23
/
50%
€19.70
Target price
13.04.24
€28.05
Performance (%)
1.02%
End price
14.04.24
€19.90
Summary
This prediction ended on 14.04.24 with a price of €19.90. With a performance of 1.02%, the SELL prediction by JPMorgan_Chase___Co_ for AnaptysBio Inc was trending in the wrong direction JPMorgan_Chase___Co_ has a follow-up prediction for AnaptysBio Inc, but this time predicts that AnaptysBio Inc is a Buy. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| AnaptysBio Inc | -20.319% | -20.319% | 149.667% | 118.155% |
| iShares Core DAX® | -0.201% | 5.471% | 9.188% | 48.662% |
| iShares Nasdaq 100 | 2.573% | 10.092% | 39.291% | 95.716% |
| iShares Nikkei 225® | 0.598% | 9.871% | 46.201% | 63.770% |
| iShares S&P 500 | 1.804% | 7.404% | 29.617% | 67.241% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread AnaptysBio Inc diskutieren
AnaptysBio, Inc. (NASDAQ: ANAB) had its price target lowered by analysts at JPMorgan Chase & Co. from $32.00 to $31.00. They now have an "underweight" rating on the stock.
Ratings data for ANAB provided by MarketBeat
In the thread Trading AnaptysBio Inc
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten